CTI BioPharma CTIC Stock
CTI BioPharma Price Chart
CTI BioPharma CTIC Financial and Trading Overview
| CTI BioPharma stock price | 9.07 USD |
| Previous Close | 9.07 USD |
| Open | 9.07 USD |
| Bid | 0 USD x 312300 |
| Ask | 0 USD x 38800 |
| Day's Range | 9.07 - 9.08 USD |
| 52 Week Range | 4.01 - 9.08 USD |
| Volume | 1.5M USD |
| Avg. Volume | 5.47M USD |
| Market Cap | 1.2B USD |
| Beta (5Y Monthly) | 0.830633 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.49 USD |
CTIC Valuation Measures
| Enterprise Value | 1.26B USD |
| Trailing P/E | N/A |
| Forward P/E | 33.59259 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 15.786819 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 16.569 |
| Enterprise Value/EBITDA | -23.437 |
Trading Information
CTI BioPharma Stock Price History
| Beta (5Y Monthly) | 0.830633 |
| 52-Week Change | 47.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.08 USD |
| 52 Week Low | 4.01 USD |
| 50-Day Moving Average | 6.95 USD |
| 200-Day Moving Average | 5.8 USD |
CTIC Share Statistics
| Avg. Volume (3 month) | 5.47M USD |
| Avg. Daily Volume (10-Days) | 2.22M USD |
| Shares Outstanding | 131.88M |
| Float | 99.89M |
| Short Ratio | 1.08 |
| % Held by Insiders | 5.49% |
| % Held by Institutions | 83.28% |
| Shares Short | 11.27M |
| Short % of Float | 15.17% |
| Short % of Shares Outstanding | 8.55% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -91.38% |
| Operating Margin (ttm) | -73.53% |
| Gross Margin | 94.11% |
| EBITDA Margin | -70.69% |
Management Effectiveness
| Return on Assets (ttm) | -28.57% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 75.77M USD |
| Revenue Per Share (ttm) | 0.62 USD |
| Quarterly Revenue Growth (yoy) | 950.79% |
| Gross Profit (ttm) | 50.43M USD |
| EBITDA | -53565000 USD |
| Net Income Avi to Common (ttm) | -69239000 USD |
| Diluted EPS (ttm) | -0.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 59.01M USD |
| Total Cash Per Share (mrq) | 0.45 USD |
| Total Debt (mrq) | 118.29M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.267 |
| Book Value Per Share (mrq) | -0.192 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -82315000 USD |
| Levered Free Cash Flow (ttm) | -85263624 USD |
Profile of CTI BioPharma
| Country | United States |
| State | WA |
| City | Seattle |
| Address | 3101 Western Avenue |
| ZIP | 98121 |
| Phone | 206 282 7100 |
| Website | https://www.ctibiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 127 |
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an an oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTI BioPharma Corp. has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. and S*BIO Pte Ltd. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.
Q&A For CTI BioPharma Stock
What is a current CTIC stock price?
CTI BioPharma CTIC stock price today per share is 9.07 USD.
How to purchase CTI BioPharma stock?
You can buy CTIC shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CTI BioPharma?
The stock symbol or ticker of CTI BioPharma is CTIC.
Which industry does the CTI BioPharma company belong to?
The CTI BioPharma industry is Biotechnology.
How many shares does CTI BioPharma have in circulation?
The max supply of CTI BioPharma shares is 131.88M.
What is CTI BioPharma Price to Earnings Ratio (PE Ratio)?
CTI BioPharma PE Ratio is 0.00000000 now.
What was CTI BioPharma earnings per share over the trailing 12 months (TTM)?
CTI BioPharma EPS is 0 USD over the trailing 12 months.
Which sector does the CTI BioPharma company belong to?
The CTI BioPharma sector is Healthcare.
CTI BioPharma CTIC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16307.16 USD — |
-3.07
|
7.01B USD — | 16066.46 USD — | 16600.37 USD — | — - | 7.01B USD — |
| NASDAQ Capital Market Composite RCMP | 99.3 USD — |
-2.27
|
— — | 98.11 USD — | 102.86 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 882.43 USD — |
-1.77
|
— — | 875.25 USD — | 895.82 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19961.28 USD — |
-3.07
|
— — | 19666.65 USD — | 20320.18 USD — | — - | — — |
- {{ link.label }} {{link}}